The life sciences sector, encompassing pharmaceuticals, biotechnology, and medical research, constantly seeks novel and highly specific chemical compounds to advance drug discovery and development. Advanced organic intermediates are the unsung heroes of this innovation, providing the complex molecular scaffolds necessary for synthesizing new active pharmaceutical ingredients (APIs) and research molecules. These specialized compounds are designed for precision, enabling chemists to build sophisticated structures with high specificity and efficiency.


A prime example of such a critical advanced organic intermediate is 4-Chloro-2-(trifluoroacetyl)aniline hydrochloride (CAS: 173676-59-0). This compound is well-known for its indispensable role as an Efavirenz intermediate supplier, serving as a vital precursor for the synthesis of Efavirenz, a key HIV-1 RT inhibitor. Its unique trifluoroacetyl and chloro-substituted aniline structure makes it a valuable building block for a range of fluorinated pharmaceutical building blocks, opening doors for diverse synthetic applications beyond just Efavirenz.


For researchers and developers in life sciences, the ability to buy high purity 173676-59-0 from a trusted 4-chloro-2-(trifluoroacetyl)aniline hydrochloride manufacturer is paramount. NINGBO INNO PHARMCHEM CO.,LTD. ensures that its product meets rigorous quality standards (assay ≥99.0%), providing a reliable and consistent source for experimental and production needs. The availability of such high-quality intermediates allows for seamless progression from laboratory-scale research to large-scale production, accelerating the pace of scientific breakthroughs.


Furthermore, sourcing this critical compound at a competitive 4-chloro-2-(trifluoroacetyl)aniline hydrochloride price without compromising on quality is essential for the economic viability of new drug projects. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting the life sciences community by providing top-tier advanced organic intermediates, facilitating the creation of the next generation of life-saving therapies and diagnostic tools.